$Amazing $Biotech & $olid $Microcap $tocks

[ash111]

$YTEN 10Q, the balance sheet remains solid, total assets/ total liabilities ratio remains at a ratio of 5. net lose reduced by 20%. that's pretty good earnings. because the company expanded it's portfolio which usually brings more expenses but not in this case. a good job. stock is worth a lot more than it trading all at this point. 2.5m float, several catalysts ahead, sufficient cash to fund operation until at least Mid-2019. a debt-free.